Amongst these patients, there was a significantly higher mortality rate of 51.2% compared to a 4.5% mortality rate in those with normal cTnI levels and no myocardial injury, signifying the serious nature of myocardial injury in COVID-19 patients [19]. This evidence concerns the gene TNNI3 and COVID-19.